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Available online 19 April 2016Senile cataract is a clouding of the lens in the aging eye leading to a decrease in vision. Symptoms may
include faded colors, blurry vision, halos around light, trouble with bright lights, and trouble seeing at
night. Thismay result in trouble driving, reading, or recognizing faces. Cataracts are the cause of half of blindness
and 33% of visual impairment worldwide. Cataracts result from the deposition of aggregated proteins in the
eye lens and lens ﬁber cells plasma membrane damage which causes clouding of the lens, light scattering,
and obstruction of vision. ROS induced damage in the lens cell may consist of oxidation of proteins, DNA
damage and/or lipid peroxidation, all of which have been implicated in cataractogenesis. The inner eye pressure
(also called intraocular pressure or IOP) rises because the correct amount of ﬂuid can't drain out of the eye.
With primary open-angle glaucoma, the entrances to the drainage canals are clear and should be working cor-
rectly. The clogging problem occurs further inside the drainage canals, similar to a clogged pipe below the
drain in a sink.
The excessive oxidative damage is a major factor of the ocular diseases because the mitochondrial
respiratory chain in mitochondria of the vital cells is a signiﬁcant source of the damaging reactive oxygen
species superoxide and hydrogen peroxide. However, despite the clinical importance of mitochondrial oxidative
damage, antioxidants have been of limited therapeutic success. This may be because the antioxidants are not se-
lectively taken up by mitochondria, but instead are dispersed throughout the body, ocular tissues and ﬂuids'
moieties.
This work is an attempt to integrate how mitochondrial reactive oxygen species (ROS) are altered in the aging
eye, along with those protective and repair therapeutic systems believed to regulate ROS levels in ocular tissues
and how damage to these systems contributes to age-onset eye disease and cataract formation.
Mitochondria-targeted antioxidants might be used to effectively prevent ROS-induced oxidation of lipids and
proteins in the innermitochondrial membrane in vivo. The authors developed and patented the new ophthalmic
compositions including N-acetylcarnosine acting as a prodrug of naturally targeted to mitochondria L-carnosine
endowed with pluripotent antioxidant activities, combined with mitochondria-targeted rechargeable antioxi-
dant (either MitoVit E, Mito Q or SkQs) as a potent medicine to treat ocular diseases. Such speciﬁcity is explained
by the fact that developed compositionsmight be used to effectively prevent ROS-induced oxidation of lipids and
proteins in the inner mitochondrial membrane in vivo and outside mitochondria in the cellular and tissue struc-
tures of the lens and eye compartments.
Mitochondrial targeting of compounds with universal types of antioxidant activity represents a promising ap-
proach for treating a number of ROS-related ocular diseases of the aging eye and can be implicated in the man-
agement of cataracts and primary open-angle glaucoma.
© 2016 Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
Aging eye
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Eye lens and aqueous humor
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and mitochondria-targeted antioxidantsn have. With one look, one can relay the most intimate message. After the connection is made, words cease to exist.
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Partially reduced metabolites of molecular oxygen (O2) are referred
to as “reactive oxygen species” (ROS) due to their higher reactivities rel-
ative to molecular O2. ROS are generated intracellularly through a vari-
ety of processes, for example, as by-products of normal aerobic
metabolism and as second messengers in various signal transduction
pathways. ROS can also be derived from exogenous sources, either
being taken up directly by cells from the extracellular milieu, or pro-
duced as a consequence of the cell's exposure to some environmental
insult. Reactive oxygen species (ROS) are generated as by-products of
cellular metabolism, primarily in the mitochondria. Although ROS are
essential participants in cell signaling and regulation, when their cellu-
lar production overwhelms the intrinsic antioxidant capacity, damageScheme 1. The production of reactive oxto cellular macromolecules such as DNA, proteins, and lipids ensues.
Such a state of “oxidative stress” is thought to contribute to the patho-
genesis of a number of age-related sight threatening eye diseases.
Oxidation of phospholipids and accumulation of their oxygenated inter-
mediates have long been considered as participants of two possibly in-
terrelated processes: cell/tissue damage and danger signaling [1].
However, direct experimental evidence supporting these views is
scarce, mostly due to technological difﬁculties in quantitative assess-
ments of peroxidized phospholipids. The traditional point of view is
that oxidative stress causes – through yet to identiﬁed mechanisms –
random free radical peroxidation of phospholipids whereby the rule of
preferable oxidation of most polyunsaturated fatty acids dominates
over the types of phospholipids based on the speciﬁcity of their polar
head-groups. In contrast, peroxidation pathways catalyzed by speciﬁcygen species (ROS) in mitochondria.
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randomly oxidize those classes of phospholipids that are localized in
the immediate proximity to the catalytic sites. Among those of particu-
lar interest in the context of peroxidation reactions are cardiolipins
(CLs), a critical phospholipid component of cellular membranes from
bacteria to mammals. The importance of CL peroxidation in mammals
is also emphasized by its critical role in the function of numerous mito-
chondrial enzymes involved in electron transport chain function and
other proteins involved in energetic metabolism which include cyto-
chrome c (cyt c) oxidase [2], creatine kinase [3], ATP synthase [4] and
the mitochondrial ADP carrier [5] among others. (See Scheme 1.)
1.1. Oxidation-induced hallmark of molecular damages in human cataracts
Cataract formation, the opaciﬁcation of the eye lens, is one of the
leading causes of human blindness worldwide, accounting for 47.8% of
all causes of blindness [6,7]. Cataracts result from the deposition of ag-
gregated proteins in the eye lens and lens ﬁber cells plasma membrane
damagewhich causes clouding of the lens, light scattering, and obstruc-
tion of vision.
Although great advances have been made in surgical treatment, the
incidence of cataracts in developing countries is so high that it over-
whelms the capacity of surgical programs. Age is by far the biggest
risk factor for cataract, and it is sometimes assumed that cataract is sim-
ply an ampliﬁcation of this aging process. This appears not to be the
case, since the lens changes associated with aging and cataract are
distinct.
This review article is an attempt to integrate howmitochondrial ROS
are altered in the aging eye, alongwith those protective and repair ther-
apeutic systems developed by Innovative Vision Products, Inc. (IVP)
(Delaware, USA) during recent years believed to regulate ROS levels in
ocular tissues and how damage to these systems contributes to age-
onset eye disease and, speciﬁcally, cataract formation.
Oxidative stress occurs when the level of prooxidants exceeds the
level of antioxidants in cells resulting in oxidation of cellular compo-
nents and consequent loss of cellular function [8]. In the anterior seg-
ment of the eye, oxidative stress has been linked to lens cataract and
glaucoma while in the posterior segment of the eye oxidative stress
has been associated with macular degeneration [8]. The aging eye ap-
pears to be at considerable risk from oxidative stress. In eye tissues, mi-
tochondria are an important endogenous source of ROS. One might
predict that over time, all ocular structures, from the tearﬁlm to the ret-
ina, undergo oxidative stress, and therefore, the antioxidant defenses of
each tissue assume the role of a safeguard against degenerative ocular
pathologies. The ocular surface and cornea protect the other ocular tis-
sues and are signiﬁcantly exposed to oxidative stress of environmental
origin. Overwhelming of antioxidant defenses in these tissues clinically
manifests as pathologies including pterygium, corneal dystrophies, and
endothelial Fuch's dystrophy. The crystalline lens is highly susceptible
to oxidative damage in agingbecause its cells and their intracellular pro-
teins are not turned over or replaced, thus providing the basis for
cataractogenesis. The trabecularmeshwork,which is the anterior cham-
ber tissue devoted to aqueous humor drainage, has a particular suscep-
tibility to mitochondrial oxidative injury that affects its endothelium
and leads to an intraocular pressure increase that marks the beginning
of glaucoma. Photo-oxidative stress can cause acute or chronic retinal
damage. The pathogenesis of age-related macular degeneration in-
volves oxidative stress and death of the retinal pigment epithelium
followed by death of the overlying photoreceptors [9]. This review out-
lines speciﬁcally the potential role of mitochondrial function and redox
balance in age-related eye diseases (age-related cataract and glauco-
ma), and detail how the carnosine dipeptide repair system, its ophthal-
mic prodrug N-acetylcarnosine lubricant eye drops and other redox
systemsplay key roles in the function andmaintenance of the aging eye.
Oxidation is the hallmark of age-related nuclear (ARN) cataract
(reviewed in Refs. [10–13]). ROS induced damage in the lens cell mayconsist of oxidation of proteins, DNA damage and/or lipid peroxidation,
all of which have been implicated in cataractogenesis (reviewed in Ref.
[14]). Loss of protein sulfhydryl groups, and the oxidation ofmethionine
residues, are progressive and increase as the cataract worsens until
N90% of cysteine and half the methionine residues are oxidized in the
most advanced form. By contrast, there may be no signiﬁcant oxidation
of proteins in the center of the lens with advancing age, even past age
80. The key factor in preventing oxidation seems to be the concentration
of nuclear glutathione (GSH). The phospholipid composition of adult
human lens membranes differs dramatically from that of any other
mammalian membrane [15]. The relative and absolute amount of
sphingolipids, including dihydrosphingomyelin and sphingomyelin, in-
creased with age, whereas glycerolipids, including phosphatidylcholine
and two phosphatidylethanolamine-related phospholipids, decreased.
These changes were exacerbated by the presence of cataract and were
substantial, greater than the changes in lipid levels reported in any
organ in association with any disease. The changes in the amount of
lipids with age and cataract support the idea that glycerolipids are
selectively oxidized over lipids with fewer double bonds, such as
sphingolipids [16]. As a result of the elevation of sphingolipid levels
with species, age, and cataract, lipid hydrocarbon chain order, or stiff-
ness, increases.
Increased membrane stiffness may increase light-scattering, reduce
calcium pump activity, alter protein–lipid interactions, and perhaps
slow ﬁber cell elongation (Fig. 1) [16].
The mammalian lens can be divided into an elongating compart-
ment in the posterior lens and a proliferation compartment in the epi-
thelium of the anterior lens. Cell division in the lens is restricted to the
proliferating compartment of the epithelial cells [17,18]. This prolifera-
tion compartment in the lens epithelium can be further divided in to
three subcompartments, related to the anatomy of the anterior lens
and a rate of cell division. Lens epithelial cells found in the proximity
of the ciliary body (equator) show the fastest mitotic rate and are re-
ferred to as the equatorial zone. Epithelial cells located in the proximity
of the iris show slower mitotic rates and are referred to as the interme-
diate zone. Finally, epithelial cells overlying the anterior suture regions
of the lens undergo little or nomitosis and are referred to as the central
zone. At the lens equator, epithelial cells of the equatorial zone differen-
tiate into ﬁber cells, producing an elongating compartment (Fig. 2A–E)
[17,18].
Oxidative stress, a major and ubiquitous stressing factor, was initial-
ly selected for investigating the cellular response to stress. Most studies
investigating such cellular response have employed examination of the
cell either during or shortly after exposure to stress. Several authors
have employed a different approach arguing that the short-term re-
sponse to stress obscures the biological changes that allow the cell to
continue to thrive in its new environment [19].
Reﬂecting this oxidation concept,murine and human cell lines capa-
ble of surviving regular exposure to toxic levels of H2O2 or tert-butyl hy-
droperoxide (TBOOH) have been developed. It was found that certain
fundamental long-term changes in cell biology had occurred. The
peroxide-resistant cells are diploid rather than aneuploid, show funda-
mental changes in the cytoskeletal cellular structure, suggesting less
rigid more ﬂexible cells, express a new lower molecular mass of p53, a
key stress protein responder involved in adaptation, and ﬁnally have
an immunochemical modiﬁcation in alpha A-crystallin, a small heat-
shock protein. Previously, it was found that there is a dramatic increase
in catalase and glutathione S-transferase activity and a remarkable lim-
ited change in expression in other antioxidative genes in these cells
(reviewed in Ref. [19]).
2. Oxidative stress, mitochondria and the apoptotic pathway
Tissues with high energy demands such as muscles, heart, liver, en-
docrine glands, brain and retina, have higher numbers of mitochondria
per cell.
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Fig. 1. Deleterious structural damage of the lens ﬁber cell plasma membranes as the primary light-scattering centers that cause the observed lens opacity.
A. Structure of the cell plasma membrane
Parts of the membrane
1) Phospholipid bilayer — two layers of phospholipids
a) head is polar… attracts water
b) tail… hates water doesn't want to be near it
2) Proteins
a) To allow stuff in and out
b) Also for cell “ID tags” — recognition proteins…
3) Carbohydrate chains
a) Attracted to proteins that work as “ID tags” … they have a pattern… similar to antlers
4) Cholesterol
a) Stabilizes the membrane
B1. Accumulation of phospholipid hydroperoxides, the secondary molecular lipid peroxidation products, in the lens ﬁber cells plasma membranes (B1,B2,C).
B2: UV absorption spectra of lipid extracts (methanol/heptane: 5:1, v/v) from aqueous humor samples obtained from human eyes: normal (control, lower curve) and mature cataract
(upper curve).
C: Electron microphotograph of the midzonal area of the human lens; ripe nuclear cataract. Bar = 1 μm.
At the stage of ripenuclear cataract,which is biochemically characterizedby large highmolecular aggregate formation in thehuman lens, anultrastructural characteristic of themembrane
lesion is distinct with the lenticular ﬁber plasma membrane twisted fragments becoming a central mass of amorphous electron-gray debris and globules of different size.
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and considerable evidence points to mitochondrial dysfunction and
ROS imbalance in the etiology of age related cataract. Distribution
of mitochondria in the lens is associated with its development [8]. The
lens is composed of cells that differentiate froman anterior layer of cuboi-
dal epithelia andmigrate posteriorly to formelongated lensﬁber cells that
make up the lens nucleus. During this process ﬁber cells synthesize high
levels of lens crystallins before losing their nuclei and mitochondria.
Thus, the single monolayer of epithelial cells that lines the anterior of
the lens, are the only lens cells that carry out aerobicmetabolismand con-
tain mitochondria aside from newly differentiated ﬁber cells.
The lens is especially susceptible to damagewith aging since lens the
cells and their cellular proteins are not turned over or replaced in this
encapsulated tissue. The proteins at the center of the eye are some of
the oldest in the body and obviously susceptible to age related oxidativedamage. Damage to the mitochondria of the epithelial cells may result
in ROS production that is thought to affect the proteins and lipid plasma
cell membranes of the underlying ﬁber cells.
Mitochondria have a signiﬁcant role in regulating apoptosis and ne-
crosis, ROS levels, cellular signaling, control of the cell cycle, and growth
and differentiation [20].
The electron transport chain generates ATP by oxidative phosphory-
lation, creating a proton gradient through sequential transfer of electrons
donated by reducing equivalents. This complex system ismade up of ﬁve
multi enzyme subunits, NADH dehydrogenase comprises complex I (46
subunits), succinate dehydrogenase is complex II (4 subunits), cyto-
chrome C reductase and cytochrome C oxidase make up complexes III
and IV respectively (11 and 13 subunits). Complex V is the ATP synthase
(16 subunits) that uses the proton gradient created by theﬁrst four com-
plexes to drive phosphorylation of ADP to form the energy rich ATP [8].
54 M.A. Babizhayev / BBA Clinical 6 (2016) 49–68In addition to the well-established role of the mitochondria in ener-
gy metabolism, regulation of cell death has recently emerged as a sec-
ond major function of these organelles. This, in turn, seems to be
intimately linked to their role as the major intracellular source ofreactive oxygen species (ROS), which are mainly generated at complex
I and III of the respiratory chain. Excessive ROS production can lead to
oxidation of macromolecules and has been implicated in mtDNAmuta-
tions, aging, and cell death [21].
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Fig. 2. A, B, C, D, E. Schematic presentation of the crystalline lens, location within the eye and the structure (1), lens epithelial cells (2) and lens ﬁber cells (3–7). The lens is a transparent
organ located behind the cornea and the iris. The outer edge of the lens consists of a single layer of epithelial cells, and amembrane that covers the entire organ. Lens epithelial cells do not
divide exceptwhenundergoing repair. Some epithelial cells lose their nuclei and other organelles, and become lensﬁber cells. At the cellular level, the evidences of amazing lens design are
clear. The lens is comprised of numerous highly elongated cells which grow like an onion (3–5). The lens ﬁbers are anucleate, ribbon-like cells located throughout the central region of the
iris (6). These cells do not have a blood supply and do not contain any nervous or connective tissue. They are full of crystallins, grown especially to attain a highly transparent lens quality
(7). B, C: Within each layer, the ﬁber cells are arranged in parallel. The alignment of the lens ﬁber cells in concentric layers is essential to lens transparency. In order to maintain their
arrangement, adjacent cells are interlocked by ball-and-socket joints at the cells' edges. This prevents movement of cells against each other during the lens shape changes associated
with focusing. D. Lens — cut in half. The long, slender epithelial cells that grow in concentric rings to form the lens. D, E. The adult lens measures about 9 mm in diameter and is
3.5 mm thick. It is completely enveloped by the thickest basement membrane in the body, the capsule (#1 in photomicrograph), which is 10–20 μm thick of hyaline material
containing type IV collagen. There is a layer of large cuboidal epithelial cells (the lens epithelium) beneath the anterior capsule (#2 in photomicrograph). In the center (#3 in
photomicrograph) tightly packed cells have lost their nuclei and become packed by special transparent proteins (crystallins) to form so-called lens ﬁbers. E, F. Schematic presentation
of a mitochondria. Mitochondria are small compartments partitioned by membranes and found exclusively in complex cells. These organelles are often called the “power plants” of the
cell because their main job is to make energy. Mitochondria are highly unusual — they contain their own genetic material and protein-making machinery enwrapped in a double
membrane. F. Mitochondria are abundant in the lens, but only within the epithelium and differentiating ﬁbers, mature ﬁbers in the core of the lens lack mitochondria. It became
widely accepted that the lens epithelium plays the most important role in lens metabolism [37–40]. It was further proposed that ions and metabolites gain access to the ﬁber cells,
which lack organelles, including mitochondria, via gap junctions connecting the closely apposed apical membranes of lens epithelial and superﬁcial cortical ﬁber cells [40].
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cell death partly due to its role as a source of ROS and due to the release
of cytochrome C and other pro-apoptotic factors that activate caspases
and trigger apoptosis. CytochromeC is a small globular heme containing
electron carrier in the electron transport chain of the mitochondria. Its
primary role in the electron transport chain is a crucial one, shuttling
electrons from complex III (ubiquinol:cytochrome c reductase) to com-
plex IV (cytochrome oxidase), however, its release from the mitochon-
dria to the cytosol is the initiating factor for the internal apoptotic
pathway. The release of cytochrome C is a two step process, initiated
by release of the hemoprotein from its binding to cardiolipin at the
inner mitochondrial membrane [21]; this results in a pool of free cyto-
chrome C in the intermembrane space. Subsequent permeabilizationof the outer mitochondrial membrane releases cytochrome C into the
cytosol where it binds apoptotic peptidase activating factor 1 (APAF1).
Mitochondria-generated ROS play an important role in the release of
cytochrome c and other pro-apoptotic proteins, which can trigger cas-
pase activation and apoptosis. Cytochrome c release occurs by a two-
step process that is initiated by the dissociation of the hemoprotein
from its binding to cardiolipin, which anchors it to the inner mitochon-
drial membrane. Oxidation of cardiolipin reduces cytochrome c binding
and results in an increased level of “free” cytochrome c in the intermem-
brane space. A central step in the mechanism of naturally-occurring or
radiation-induced apoptosis is damage to the mitochondria through
the action of free radicals and reactive intermediates of peroxidase com-
plexes of cytochrome c on a mitochondria-speciﬁc phospholipid,
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outer mitochondrial membrane, formation of the peroxidase cyto-
chrome c/cardiolipin complex, peroxidation of cardiolipin, detachment
of cytochrome c from the membrane, mitochondrial permeabilization
and release of cytochrome c, along with other pro-apoptosis factors,
from mitochondria into the cytochromeosol designate a point of no re-
turn in the process of apoptosis [22,25,26]. A likely essential role of
cardiolipin peroxidation products in mitochondrial permeabilization is
supported by the ability of oxidized cardiolipin to release Smac/Diablo
from mitochondria isolated from cytochrome c-deﬁcient cells [22]. Su-
peroxide radicals and their dismutation product, H2O2, produced spon-
taneously or via superoxide dismutase-catalyzed reactions, are essential
for feeding the peroxidase cycle of cardiolipin oxidation [22,26]. For this
reason, elimination of intracellular ROS, particularly its major source,
mitochondrial ROS, by antioxidants may be effective in protecting cells
against apoptosis. Conversely, mitochondrial antioxidant enzymes pro-
tect from apoptosis. Hence, there is accumulating evidence supporting a
direct link betweenmitochondria, oxidative stress and cell death [21]. It
is suggested that mitochondrial-induced ROS production promotes
cytochrome c release from mitochondria by a two-steps process,
consisting of the dissociation of this protein from cardiolipin, followed
by permeabilization of the outer membrane, probably by interaction
with voltage-dependent anion channel (VDAC). The published data
may help clarify themolecularmechanism underlying the release of cy-
tochrome c from themitochondria to the cytosol and the role of ROS and
cardiolipin in this release [27].
Oxidative stress has long been recognized as an important mediator
of apoptosis in lens epithelial cells and also plays an important role in
the pathogenesis of cataracts [28–31]. Apoptosis is a physiologic process
of cell death that plays a critical role in a variety of biologic systems,
which has been identiﬁed as providing an important molecular basis
for both the initiation and progression of cataracts [32,33]. The lens ep-
ithelial cells differentiate into lens ﬁber cells through a process, which
utilizes the same regulators as those in apoptosis at multiple signaling
steps. In addition, introduction of exogenous wild-type or mutant
genes or knock-out of the endogenous genes leads to apoptosis of the
lens epithelial cells followed by absence of the ocular lens or formation
of abnormal lens. Finally, both in vitro and in vivo studies have shown
that treatment of adult lens with stress factors induces apoptosis of
lens epithelial cells, which is followed by cataractogenesis [32]. The re-
sults provide evidence for the involvement of an oxidative process in
the apoptosis elicited by TGF-beta(2) (transforming growth factor
beta(2) (TGF-beta(2)), a growth regulator of human lens epithelial
cells (HLECs)) in HLECs [31].
The lens exists in an environment that is rich in endogenous sources
of reactive oxygen species (ROS) and phospholipid hydroperoxides,
which are produced by the high local oxygen concentration, the chronic
exposure to light, and the pathogenic activities of lens epithelial cells
(Fig. 2A–E) [34]. Lipid peroxidation (LPO) was about three times higher
after growth in a hyperoxic atmosphere comparedwith cells grown in a
normoxic atmosphere. The lack of change in the relative amount of
sphingomyelin and the decrease in phosphatidylcholine coupled with
the increase in lysophosphatidylcholine support the idea that similar
mechanisms may be responsible for the lipid compositional changes
in both lens epithelial and ﬁber cells. It is postulated that lipases elimi-
nate oxidized unsaturated glycerolipids, leaving a membrane increas-
ingly composed of more ordered and more saturated sphingolipids
[34]. Oxidative stress leads to changes in membrane composition that
are consistent with those seen with age in human epithelial cells.
Oxidation-induced epithelial phospholipid change is an area of research
that has gone virtually unexplored in the human lens and could be rel-
evant to all cell types and may be important to lens clarity [34]. These
results support the free radical theory of aging and reinforce the impor-
tance of mitochondria as a source of these radicals. Since H2O2 is a rela-
tively stable and readily diffusible molecule a number of systems exist
to limit its damaging potential. These include catalase, glutathioneperoxidase and the peroxiredoxins. Mitochondrial localization of cata-
lase appears to be restricted to heart mitochondria, however, overex-
pression of catalase targeted to mitochondria in mice extended
lifespan and delayed cataract formation [35] indicating the importance
of eliminating the toxic effects of H2O2 in lens cells. Peroxiredoxins
(Prxs) are a ubiquitous family of antioxidant enzymes that also control
cytokine-induced peroxide levels which mediate signal transduction
in mammalian cells. Prxs can be regulated by changes to phosphoryla-
tion, redox and possibly oligomerization states. Prxs are divided
into three classes: typical 2-Cys Prxs; atypical 2-Cys Prxs; and 1-Cys
Prxs. All Prxs share the same basic catalytic mechanism, in which an
active-site cysteine (the peroxidatic cysteine) is oxidized to a sulfenic
acid by the peroxide substrate. The recycling of the sulfenic acid back
to a thiol is what distinguishes the three enzyme classes [36].
Peroxiredoxins use redox active cysteines to reduce and detoxify
H2O2, peroxynitrite and a wide range of organic hydroperoxides [36].
The peroxiredoxin III enzyme was found to be redox sensitive in lens
cells and is localized to human lens and mitochondria of lens epithelial
cells [37].
These data demonstrate that PRDX3 is present throughout the lens
and localized to the mitochondria in lens epithelial cells. PRDX3 was
speciﬁcally induced by low levels of H2O2 in human lens epithelial
cells and rat lenses suggesting that induction of PRDX3 is an acute re-
sponse of the lens to increased H2O2 levels. These data provide evidence
for an important role for PRDX3 in lens H2O2-detoxiﬁcation, mitochon-
drial maintenance, and possibly cataract formation [37].
Although multiple physiologic defenses exist to protect the lens
from the toxic effects of light and oxidative damage, mounting evidence
suggests that chronic exposure to oxidative stress over the long-term
may damage the lens and predispose it to cataract development [38,39].
3. The relation of mitochondria to age-onset eye disease
Maintaining the redox balancewithin themitochondria is critical for
cellular homeostasis since the mitochondria house the energy produc-
ing systems of the cell and it is widely recognized that damage to the
mitochondria plays a key role in aging and age-related disorders. Pro-
duction of reactive oxygen species (ROS) species such as the hydroxyl
radical (•OH), singlet oxygen (1O2), hydrogen peroxide (H2O2) and
peroxynitrite (OONO−) is ﬁnely balanced with sophisticated antioxi-
dant and repair systems located in this complex organelle. Loss of
these antioxidant and scavenging systems leads to protein and lipid
membrane oxidations that are hallmarks of many ocular diseases in-
cluding cataract, glaucoma and retinal degeneration [8].
Mitochondrial protection and repair is mediated by the reducing
agents, primary antioxidants and chaperones, antioxidant enzymes
and speciﬁc protein repair systems. In the mitochondria all of the sys-
tems work in concert to protect against ROS-induced damage [8].
Reducing systems in themitochondria employ electron donors such
as glutathione (GSH), thioredoxin (Trx), NADPH, NADH, FADH2
and certain amino acids. Reducing equivalents act as important electron
donors in order to maintain the redox status of a number of essential
proteins and aid antioxidant enzyme systems. In the eye, GSH is a pri-
mary protectant of lens, cornea, and retina against ROS induced damage
[8,40]. The eye lens in particular contains high levels of reduced GSH, in
cataractous lenses GSHhas been shown to be depleted by up to 60% [31]
while GSH levels have been shown to decrease with age particularly in
the nucleus of the lens [8,41].
A critical mitochondrial protective and repair system for the eye and
other tissues employs repair enzymes that operate on protein sulfhydryl
groups sensitive to oxidative stress. Thesemoieties can easily conjugate
with nonprotein thiols (S-thiolation) to form protein-thiol mixed
disulﬁdes. A number of systems exist to combat and/or repair this
type of oxidative damage. The glutathione (GSH) system, consisting of
reduced GSH, oxidized glutathione (GSSG) and a number of related en-
zymes, is the main redox control system of the cell. The GSH system
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tains protein thiols in a reduced state. Glutathione peroxidase reduces
H2O2 to water with the concomitant oxidation of GSH to GSSG; GSH is
maintained in its reduced form by the enzyme glutathione reductase
in an NADPH dependent reaction [8]. A reduction in glutathione perox-
idase and glutathione reductase activities has been observed in catarac-
tous lenses, but this may be a consequence of lens injury rather than the
cause [40]. Glutathione and the related enzymes belong to the defense
systemprotecting the eye against chemical and oxidative stress. This re-
view focuses on GSH and two key enzymes, glutathione reductase and
glucose-6-phosphate dehydrogenase in lens, cornea, and retina. Lens
contains a high concentration of reduced glutathione, which maintains
the thiol groups in the reduced form [40]. These contribute to lens com-
plete transparency as well as to the transparent and refractive proper-
ties of the mammalian cornea, which are essential for proper image
formation on the retina. In cornea, glutathione also plays an important
role in maintaining normal hydration level, and in protecting cellular
membrane integrity. In retina, glutathione is distributed in the different
types of retinal cells. Intracellular enzyme, glutathione reductase, in-
volved in reducing the oxidized glutathione has been found at highest
activity in human and primate lenses, as compared to other species. Be-
sides the enzymes directly involved in maintaining the normal redox
status of the cell, glucose-6-phosphate dehydrogenase which catalyzes
the ﬁrst reaction of the pentose phosphate pathway, plays a key role
in protection of the eye against reactive oxygen species [40]. Another
vital system acting on free and mixed disulﬁdes in the lens is the
thioltransferase system which uses reduced GSH for reduction of pro-
tein thiols to prevent disulﬁde bond formation and potentially protein
aggregation. Mitochondrial thioltransferase or glutaredoxin 2 has been
shown to protect against disruption of the mitochondrial transmem-
brane potential during oxidative stress in lens epithelial cells [42].
Thioltransferase (or Grx) belongs to the oxidoreductase family and is
known to regulate redox homeostasis in cells.
Mitochondrial Grx2 is a recent discovery, but its function is largely
unknown. Grx2 has a novel function as a peroxidase, accepting
electrons both from GSH and thioredoxin reductase (TT) [43]. This
unique property may play a role in protecting the mitochondria from
oxidative damage. Xing and Lou [44] showed that overexpression of
thioltransferase in HLE-B3 cells enhanced protection against H2O2
induced oxidative stress. These data indicate a new physiological func-
tion of TTase, which involves in the reactivation of the oxidatively
inactivated enzymes through dethiolation; thus this redox-regulating
enzyme can protect the human lens epithelial cells and maybe other
cell types by preventing them from permanent oxidative damage [44].
The cited authors also showed that cellular thioltransferase activity
was inhibited by addition of cadmium to the medium [44].
Thioredoxin 2 (Trx-2) is a small redox protein containing the
thioredoxin active site Trp-Cys-Gly-Pro-Cys that is localized to themito-
chondria by a mitochondrial leader sequence and encoded by a nuclear
gene (Trx-2). Trx-2 plays an important role in cell viability and the reg-
ulation of apoptosis in vitro. The mitochondrial form of thioredoxin,
thioredoxin 2 (Txn2), plays an important role in redox control and pro-
tection against ROS-induced mitochondrial damage. The mitochondrial
thioredoxin system consists of thioredoxin 2 (Trx2) and thioredoxin re-
ductase 2 (TrxR2) and also works tomaintainmitochondrial proteins in
their reduced state. Mitochondrial Trx 2 haploinsufﬁciency (a single
functional copy of a gene, where insufﬁcient product is produced) in
micewas shown to reduce ATP production and increase ROS production
[45,46]. In addition, absence of Trx2 causes early embryonic lethality in
mice [46].
Thioredoxin, like GSH, must also be maintained in its reduced state,
the enzyme thioredoxin reductase reduces thioredoxin in a NADPH de-
pendent reaction. NADPH, the source of which is the pentose phosphate
pathway (PPP), also acts as a reducing agent for glutathione reductase,
whichmaintains GSH in its reduced state. Under conditions of oxidative
stress the PPP can increase NADPH production making it of keyimportance in cellular redox control [47]. NADH and FADH are formed
during glycolysis, fatty acid oxidation and the citric acid cycle and are
funneled into the electron transport chain of the mitochondria to act
as electron donors. NADH transfers electrons to complex I of the elec-
tron transport chain while FADH2 transfers to complex II during the ox-
idation of succinate to fumarate.
Damage to themitochondria of the lens epithelial cells may result in
ROS production that is thought to affect the proteins of the underlying
ﬁber cells [8]. The central retinamediates high acuity vision, and its pro-
gressive dysfunction due to macular degeneration is the leading cause
of visual disability among adults in industrialized societies [48]. The ret-
ina is the most oxygen consuming tissue in the body with consumption
level around 50% higher than the brain or kidneys [48]. In the retina,mi-
tochondria are found throughout but the highest number of mitochon-
dria per cell is found in the photoreceptors (reviewed in Ref. [8]).
Antioxidant enzymes present in the mitochondria work in concert
with the reducing and protein repair systems and many have been
shown to be crucial for protection against ROS mediated damage and
cell death in the eye. Among the critical antioxidant enzymes that pro-
tect the cells against oxidative stress are superoxide dismutases:
CuZnSOD (SOD 1) and MnSOD (SOD 2). The latter is also implicated in
apoptosis [8,49–52]. MnSOD (SOD 2) in the mitochondrial matrix con-
verts O2−• generated by the electron transport chain to hydrogen perox-
ide. Up and down-regulation of SOD 2 has been shown to be important
for protection of lens epithelial cells against oxidative stress [8,49]. Gene
knockouts serve as useful experimentalmodels to investigate the role of
antioxidant enzymes in protection against oxidative stress in the lens. In
the absence of gene knockout animals for Mn-containing superoxide
dismutase (MnSOD), the effect of this enzyme on oxidative stress was
investigated in a human lens epithelial cell line (SRA 01/04) in which
the enzyme was up- or downregulated by transfection with sense and
antisense expression vectors for MnSOD. These ﬁndings demonstrate
the protective effect of MnSOD in antioxidant defense of cultured lens
epithelial cells [49]. CuZnSOD (SOD 1) is present in the intermembrane
space in some cells types, where it also converts O2−• to H2O2 permitting
further diffusion into the cytosol [50]. Overexpression of SOD 1 inwhole
lens has been shown to prevent H2O2-mediated damage in the lens and
thus was proposed to help prevent cataract, although this overexpres-
sion was not mitochondrial speciﬁc [51]. Reddy et al. [52] found that
in SOD 2 deﬁcient lens epithelial cells challenged with superoxide
therewere dramaticmitochondrial changes, cytochrome C leakage, cas-
pase 3 activation and increased apoptotic death. The functional role of
Sod2 in apoptosis was examined in cultured human lens epithelial
cells [52]. Cells with higher enzyme levels were more resistant to the
cytotoxic effects of H2O2, O2−• and UV-B radiation. Furthermore, SOD2-
deﬁcient cells showed dramatic mitochondrial damage, cytochrome C
leakage, caspase 3 activation and increased apoptotic cell death when
they were challenged with O2−•.
Thus, mitochondrial enzyme (SOD2) deﬁciency plays an important
role in the initiation of apoptosis in the lens epithelium [52].
There are distinct mechanisms that execute apoptosis according to
various different apoptotic stimuli, and these are classiﬁed into the
mitochondria-dependent pathway (intrinsic pathway) and the death
receptor-dependent pathway (extrinsic pathway). Previous studies
have demonstrated the capacity of antioxidant protection of the
mitochondria-dependent pathway associated with lens opaciﬁcation
in cultured lenses [7,53–66]. Mitochondrial damage results in the re-
lease of cytochrome c from the impaired mitochondria into the cyto-
plasm, which contributes to programmed cell death [57].
4. The role of molecular chaperone proteins in ocular tissues and for
mitochondrial function
Mitochondria contribute signiﬁcantly to the cellular production of
reactive oxygen species (ROS). The deleterious effects of increased
ROS levels have been implicated in a wide variety of pathological
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quality control mechanisms are thought to protect protein functions
in the presence of elevated ROS levels. The reactivities of molecular
chaperones and proteases removes damaged polypeptides, maintaining
enzyme activities, thereby contributing to cellular survival both under
normal and stress conditions [58].
In addition to free radical scavengers chaperones are believed to be
essential for mitochondrial function and to play important roles in eye
disease. The mitochondrion contains two speciﬁc molecular chaper-
ones, Hsp 70 and Hsp 60 [8].While Hsp 60 appears to be particularly in-
volved in protecting against protein misfolding, the house-keeping
functions of the Hsp70 chaperones include transport of proteins be-
tween cellular compartments, degradation of unstable and misfolded
proteins, prevention and dissolution of protein complexes, folding and
refolding of proteins, uncoating of clathrin coated vesicles, and control
of regulatory proteins [59]. The human heat shock protein 70 (Hsp70)
family contains at least eight homologous chaperone proteins.
Endoplasmatic reticulum and mitochondria have their speciﬁc
Hsp70 proteins, whereas the remaining six family members reside
mainly in the cytosol and nucleus. These important proteins may pro-
vide a means of protecting damaged protein in the aging eye and may
play a role in the pathogenesis of a number of maculopathies where
protein aggregation appears to be the cause [8]. In addition to the
large heat shock proteins, small heat shock proteins are also believed
to play key roles. The small heat shock protein α-crystallin, which is
the major protein of the mammalian lens, is an aggregate assembled
from two polypeptides (αA and αB). Each polypeptide has a molecular
weight around 20,000 kDa and these structural proteins are known to
act as molecular chaperones [60]. Alpha A-crystallin (alpha A) and
alpha B-crystallin (alpha B) are among the predominant proteins of
the vertebrate eye lens. In vitro, the alpha-crystallins, which are isolated
together as a high molecular mass aggregate, exhibit a number of prop-
erties, themost interesting of which is their ability to function asmolec-
ular chaperones for other proteins. Both proteins appear to have
extensive nonlens roles [61]. Brady et al. [60] showed that in αA
crystallin knockoutmice the lenses were smaller thanwild type and de-
veloped opaciﬁcation in the nucleus of the lens that becamewidespread
with age. Alpha A is essential for maintaining lens transparency, possi-
bly by ensuring that alpha B or proteins closely associated with this
small heat shock protein remain soluble [62]. In the retina, studies on
RPE from wild type and αA and αB knockout mice showed that both
proteins were localized to the mitochondria and that a lack of alpha
crystallins rendered RPEmore susceptible to apoptosis following oxida-
tive stress [63]. Lack of alpha-crystallins renders RPE cells more suscep-
tible to apoptosis from oxidative stress. Mitochondrial alpha-crystallins
may play an important role in the protection from increased susceptibil-
ity of RPE in oxidative stress [63]. It may be that a loss of crystallin chap-
erone activity during oxidative stress may lead to RPE death and
contribute to the pathogenesis of macular degeneration.
5. Reactive oxygen species and themitochondria of vertebrate lenses
The key function of mitochondria is energy production through oxi-
dative phosphorylation and lipid oxidation (Fig. 2F) [64]. The process
takes place in the cellular structures of ocular tissues within the mito-
chondrial inner membrane and includes ﬁve multi-subunit enzyme
complexes. Several other metabolic functions are performed by mito-
chondria including urea production, heme and non-heme iron biogene-
sis, steroid biogenesis, intracellular Ca2+ homeostasis, and interaction
with the endoplasmic reticulum.
Formany of thesemitochondrial functions, there is only a partial un-
derstanding of the components involved, with even less information on
mechanisms and regulation [65,66].
Growth of the ocular lens is directed by the division and differentia-
tion of a single layer of epithelial cells located at the equatorial region. It
is conceivable that this region of the lens capsule presents a specialmicroenvironment modulated by molecular cues emanating from the
surrounding tissues [61]. General knowledge of the structure of mito-
chondria has paralleled the development of techniques for the prepara-
tion of ﬁxed biological samples for electron microscopy. Early electron
microscopy studies of mitochondria of vertebrate lenses showed an ab-
sence of mitochondria in lens ﬁber cells and the presence of very few,
short mitochondria in the epithelial cells [61].
It became widely accepted that the lens epithelium plays the most
important role in lens metabolism [67–69]. It was further proposed
that ions andmetabolites gain access to theﬁber cells,which lack organ-
elles, including mitochondria, via gap junctions connecting the closely
apposed apical membranes of lens epithelial and superﬁcial cortical
ﬁber cells [69]. The permeability results suggest that the lens cells are
capable of metabolic cooperation, mediated by an extensive gap junc-
tion network [69]. The hypothesis that normal ﬁber cell metabolism is
maintained by epithelial cells has prompted numerous studies of the
role of epithelial cell dysfunction and its role in lens damage.
In recent years the basic understanding of mitochondrial morpholo-
gy and distribution has been enhanced by advances in confocal micros-
copy that permits imaging of living cells with the aid of ﬂuorescent dye
technology. Recent studies using speciﬁc ﬂuorescent dyes and confocal
microscopy of live chick [70], rat [56], and bovine lenses [71,17] show
that both the epithelial cells and the superﬁcial cortical ﬁber cells of
the lens contain numerous metabolically active mitochondria, sug-
gesting that the superﬁcial cortical ﬁber cells play a much more
active role in lens metabolism than previously suspected. In order
to elucidate the correlation between lens optical function andmetabolic
function, in vitro bovine lens optical quality and mitochondrial
integrity was measured following treatment with carbonyl cyanide m-
chlorophenylhydrazone (the mitochondrial depolarizing agent, CCCP).
The results of this study indicate that lens optical function and
mitochondrial integrity are closely correlated [71]. There appears to
be little or no information regarding mitochondrial movement in
the lens. The recent study, using confocal scanning laser microscopy,
reports the dynamic movement of the mitochondria speciﬁc dye
tetramethylrhodamine ethyl ester (TMRE) in the epithelium and super-
ﬁcial cortex of whole live bovine lenses [72]. The observedmovement of
TMRE across a mitochondrial network could represent change in the
distribution of potential across the inner membrane, presumably
allowing energy transmission across the cell from regions of low to re-
gions of high ATP demand [72].
The recent recognition of mitochondria as an arbiter of the life and
death of cells has drawn awareness to the need to develop antioxidants
and other cytoprotective agents targeted to mitochondria. Physiologi-
cally, mitochondria perform a variety of key cellular vital regulatory
processes, including ATP production, reactive oxygen species (ROS)
generation and detoxiﬁcation, and apoptosis [66].
The mitochondrial electron-transport chain is the main source of
ROS during normal metabolism [68,69]. The rate of ROS production
frommitochondria is increased in a variety of pathologic conditions in-
cluding hypoxia, aging, and chemical inhibition of mitochondrial respi-
ration (reviewed in Ref. [73–75]).
Key to many oxidative stress conditions are alterations in the efﬁ-
ciency of mitochondrial respiration resulting in superoxide (O2−•) pro-
duction [8]. Superoxide production precedes subsequent reactions
that form potentially more dangerous reactive oxygen species (ROS)
species such as the hydroxyl radical (OH•), hydrogen peroxide H2O2
and peroxynitrite (OONO−). The major source of ROS in the mitochon-
dria, and in the cell overall, is leakage of electrons from complexes I and
III of the electron transport chain. It is estimated that 0.2–2% of oxygen
taken upby cells is converted to ROS, throughmitochondrial superoxide
generation, by the mitochondria [8]. Generation of superoxide at com-
plexes I and III has been shown to occur at both the matrix side of the
inner mitochondrial membrane and the cytosolic side of themembrane
[8]. While exogenous sources of ROS such as UV light, visible light, ion-
izing radiation, chemotherapeutics, and environmental toxins may
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signiﬁcant contribution to ROS production affecting the aging process.
In addition to producing ROS, mitochondria are also a target for ROS
which in turn reducesmitochondrial efﬁciency and leads to the genera-
tion of more ROS in a vicious self-destructive cycle. Consequently, the
mitochondria have evolved a number of antioxidant and key repair sys-
tems to limit the damaging potential of free oxygen radicals and to re-
pair damaged proteins [8].
Complex I and complex III of the electron-transport chain are the
major sites for ROS production [76–78]. The highest rate of superoxide
(O2−•) generation in mitochondria not inhibited with any toxin is ob-
served in complex I during the reverse transfer of electrons from succi-
nate to NAD+ at the maximum proton potential (i.e. in the absence of
ADP). This rate equal to 1 nmol O2/mg protein perminute is nearly ﬁve-
fold higher than the rate of O2−• production in complex III under the
same conditions [74]. It is 10% of the respiration rate without ADP
(in state 4) and about 1.5% of the maximal respiration rate in the pres-
ence of ADP (in state 3). Even if this rate is lowered because of partial in-
hibition by NADH [74], a rather large amount of generated superoxide
may be dangerous for the cell due to the high toxicity of O2−• and prod-
ucts formed from O2−•. In fact, we consider themitochondria a potential
generator of strong toxins and oxidants, which can easily kill the cells.
This catastrophe will be caused not only by the direct toxic action of
ROS, but as a consequence of triggering apoptosis and necrosis which
are induced by ROS [79].
Complex I inhibition by rotenone can increase ROS generation in
submitochondrial particles [77,78,80]. The oxidation of either complex
I or complex II substrates in the presence of complex III inhibition
with antimycin A increases ROS [80,81,82]. However, the major site of
production of reactive oxygen species in mitochondria oxidizing com-
plex I substrates remains unclear. For comparison, in the pathologic
condition of myocardial ischemia, administration of rotenone decreases
the production of ROS [83] and ameliorates damage to mitochondria
during ischemia in the isolated rat heart [75]. These data suggest that ro-
tenone inhibition of complex I decreases rather than increases ROS pro-
duction by mitochondria during ischemia [75]. In summary, oxidation
and reduction reactions clearly play a signiﬁcant role in pathogenesis
of eye disease, including onset of cataracts. Multiplemitochondrial anti-
oxidant and repair systemswork in concert tomaintain transparency in
the lens and retinal function.
6. Oxidative stress-induced damages in glaucoma
Glaucoma is the main cause of irreversible blindness worldwide.
This disease is characterized by apoptosis of retinal ganglion cells
(RGC) and visual ﬁeld loss that seems to be related to elevated intraoc-
ular pressure (IOP). Several lines of evidences have implicated the cru-
cial role of mitochondrial dysfunction in the pathogenesis of
glaucoma. Increased mitochondrial oxidative stress in RGC may under-
lie or contribute to susceptibility of RGC to apoptosis.
The molecular basis of POAG is mostly unknown. Several theories of
its pathogenesis have been proposed, including mechanic and ischemic
ones (reviewed in ref. [84]). The etiology of these conditions is thought
to ﬁt with the ‘free radical theory’ of aging which postulates that aging
and age-related diseases result from the accumulation of cellular
damage from ROS. Oxidation–reduction mechanisms have special im-
portance in the eye. Oxidative damage can result in a number of molec-
ular changes that contribute to the development of glaucoma, cataract,
and other eye diseases [85,86]. If the free radical theory of aging is ap-
plied to the eye, an altered antioxidant/oxidant balance should be evi-
dent for age-related ocular diseases, such as age-related macular
degeneration, cataract, and glaucoma [87].
The studies investigating the relation between POAG, oxidant stress,
and antioxidant systems were carried out at the tissue and cellular
levels. ROS are generated as by-products of cellularmetabolism, primar-
ily in the mitochondria. Although ROS are essential participants in cellsignaling and regulation, when their cellular production overwhelms
the intrinsic antioxidant capacity, damage to cellular macromolecules
such as DNA, proteins, and lipids ensues. Such a state of “oxidative
stress” is thought to contribute to the pathogenesis of a number of neu-
rodegenerative diseases. Growing evidence supports the involvement
of oxidative stress as a common component of glaucomatous neurode-
generation in different subcellular compartments of retinal ganglion
cells (RGCs) (Fig. 3). Besides the evidence of direct cytotoxic conse-
quences leading to RGC death, it also seems highly possible that ROS
are involved in signaling RGC death by acting as a second messenger
and/or modulating protein function by redox modiﬁcations of down-
streameffectors through enzymatic oxidation of speciﬁc amino acid res-
idues. Different studies provide cumulating evidence, which supports
the association of ROS with different aspects of the neurodegenerative
process. Oxidative protein modiﬁcations during glaucomatous neuro-
degeneration increase neuronal susceptibility to damage and also lead
to glial dysfunction. Oxidative stress-induced dysfunction of glial
cells may contribute to spreading neuronal damage by secondary de-
generation. Oxidative stress also promotes the accumulation of ad-
vanced glycation end products in glaucomatous tissues. In addition,
oxidative stress takes part in the activation of immune response during
glaucomatous neurodegeneration, as ROS stimulate the antigen pre-
senting ability of glial cells and also function as co-stimulatory mole-
cules during antigen presentation [88]. The trabecular meshwork
(TM) plays an important role in primary open-angle glaucomas. Indeed,
the TM is the ocular tissue structure, throughwhich the aqueous humor
ﬂows from the anterior chamber to Schlemm's canal and collecting
channels. Until recently, the TM, which is constituted by endothelial-
like cells, was described as a kind of passive ﬁlter. The cells delineating
the structures of the collagen framework of the TM are endowed with
a cytoskeleton, and are thus able to change their shape. These cells
also have the ability to secrete the extracellularmatrix, which expresses
proteins, such as ﬁbronectin, thrombospondin and cytokines, and are
capable of phagocytosis and autophagy. The cytoskeleton is attached
to the nuclearmembrane and can, inmillionths of a second, send signals
to the nucleus in order to alter the expression of genes in an attempt to
adapt to biomechanical insult. Oxidative stress, as happens in aging, has
a deleterious exaggerating effect on the TM, leading eventually to cell
decay, tissue malfunction, subclinical inﬂammation, changes in the ex-
tracellular matrix and cytoskeleton, altered motility, reduced outﬂow
facility and (ultimately) increased intraocular pressure (IOP). TM failure
in primary open-angle glaucoma is the most relevant factor in the cas-
cade of events characteristic to glaucoma disease triggering apoptosis
in the inner retinal layers, including ganglion cells [89–91].
7. Targetingmitochondria during therapeutic treatment of cataracts
and cellular structures of tissues in anterior eye chamber
Themajor function of mitochondria in human cells is to provide ATP
by oxidative phosphorylation. However, mitochondria havemany other
roles including the modulation of intracellular calcium concentration
and the regulation of apoptotic cell death. Furthermore, the mitochon-
drial respiratory chain is a major source of damaging free radicals [92].
Therefore, strategies to preventmitochondrial damage or tomanipulate
mitochondrial function in ophthalmic clinically useful ways may pro-
vide new therapies for a range of human disorders, including age-
related cataracts. Accordingly, mitochondria are a potentially important
target for drug delivery and there are several technologies developed to
deliver bioactive molecules selectively to mitochondria within cells.
The above sections of the article demonstrate thatmitochondrial ox-
idative damage contributes to a range of ocular sight threatening
degenerative diseases, including cataracts. Consequently, the selective
inhibition ofmitochondrial oxidative damage is a promising therapeutic
strategy. One way to do this is to invent antioxidants that are
selectively accumulated into mitochondria within ophthalmic patients,
including those disabledwith age-related cataracts. In addition, because
Fig. 3. Primary open-angle glaucoma. The glaucomas are a group of chronic progressive
optic neuropathies that have in common characteristic morphologic changes at the optic
nerve and retinal nerve ﬁber layer.
Factors associated with the glaucomas
• Unphysiologic intraocular pressure
• Aqueous outﬂow restrictions
• Abnormal ocular perfusion
• Abnormal rates of apoptosis
• Other factors
Glaucomatous optic atrophy
• Changes in coloration
• Enlargement of the optic cup
• Wipeout of the neuroretinal rim
• Fallout of the retinal nerve ﬁber layer.
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targeting has the potential to protect, repair or kill the cells selectively,
and may become a key tool in the development of gene therapy for mi-
tochondrial DNA diseases [93].
In the past ten years, the search for new protective remedies against
damage caused by excessive free radical formation in mitochondria has
accelerated. Similar to our body's and organ's own natural defenses
against ROS, research has been primarily focused onmolecules combin-
ing antioxidant utilities with recycling capacities [94,95]. Incomplete
scavenging of ROS and RNS particularly affects the mitochondrial lipid
cardiolipin (CL), triggers the release of mitochondrial cytochrome c,
and activates the intrinsic death pathway [95]. Due to the active redox
environment and the excess of NADH andATP at the innermitochondri-
almembrane, a broad range of agents including electron acceptors, elec-
tron donors, and hydride acceptors can be used to inﬂuence the
biochemical pathways. The key to therapeutic value is to enrich selec-
tive redox modulators at the target sites [95]. Large doses of antioxi-
dants proved ineffective at preventing oxidative damage in animal
disease models, presumably because the antioxidants and proteins
such as manganese superoxide dismutase (MnSOD) cannot penetrate
cell membranes effectively and therefore do not reach the relevant
sites of ROS and RNS generation. One solution to this general problem
is to attach a molecule with antioxidant properties onto a vehicle that
can penetrate both the cellular and outer mitochondrial membranes
and thereby deliver the “payload” to a site where it can scavenge ROS
and ameliorate oxidative damage (Fig. 4). Since the mitochondrial
membrane spans across a negative potential, most agents have a posi-
tively charged moiety that takes advantage of electrostatic forces in lo-
cating its target [95]. Alternative chemistry-based approaches to
targeting mitochondria include the use of proteins and peptides, as
well as the attachment of payloads to lipophilic cationic compounds,
sulfonylureas, anthracyclines, and other agents with proven orhypothetical afﬁnities formitochondria.Manganese superoxide dismut-
ase (MnSOD), SS tetrapeptides with 2′,6′-dimethyltyrosine (Dmt) resi-
dues, rhodamine, triphenylphosphonium salts, nonopioid analgesics,
adriamycin, and diverse electron-rich aromatics and stilbenes were
used to inﬂuence mitochondrial biochemistry and the biology of
aging. Some general structural principles for effective therapeutic
agents are now emerging. Among these are the presence of basic or pos-
itively charged functional groups, hydrophobic substructures, and,most
promising for future selective strategies, classes of compounds that are
actively shuttled into mitochondria, bind to mitochondria-speciﬁc pro-
teins, or show preferential afﬁnity to mitochondria-speciﬁc lipids [95].
Mitochondrial function can be manipulated selectively by targeting
bioactive compounds to mitochondria in living cells. Current targeting
mechanisms involve harnessing either the mitochondrial membrane
potential or the mitochondrial protein-import machinery to take up
molecules linked to lipophilic cations or mitochondrial signal peptides,
respectively. One solution to this general problem is to attach a mole-
cule with antioxidant properties onto a vehicle that can penetrate
both the cellular and outer mitochondrial membranes and thereby de-
liver the “payload” to a site where it can scavenge ROS and ameliorate
oxidative damage (Fig. 3). Since the mitochondrial membrane spans
across a negative potential, most agents have a positively charged
moiety that takes advantage of electrostatic forces in locating its target.
The use of lipophilic cations as selective targeting agents has been
explored to capitalize on this physiological phenomenon. Research
included the series of papers published in 1969–1970, where
mitochondria-addressed penetrating synthetic cations were described
and the idea to use these cations as “electric locomotives” targeting
non-charged compounds to mitochondria was put forward [96,97].
Such mitochondria-targeted antioxidants have been developed by con-
jugating the lipophilic triphenylphosphonium cation to an antioxidant
moiety, such as ubiquinol or alpha-tocopherol. Furthermore, because
of their positive charge they are accumulated several-hundredfold
within mitochondria driven by the membrane potential, enhancing
the protection ofmitochondria from oxidative damage [98]. These com-
pounds pass easily through all biological membranes, including the
ocular-blood barrier, and thus reach those ocular tissues most affected
by mitochondrial oxidative damage. Murphy and coworkers initiated
the practical realization of the theoretical concept of mitochondria-
targeted antioxidants [92,93,97–99]. They synthesized and tested just
a few ofmitochondria-targeted antioxidants conjugated to the lipophil-
ic alkyltriphenylphosphonium cations.
Based on the published studies, the ubiquinonemoiety linked to tri-
phenylphosphonium cation by C10 aliphatic chain, MitoQ (Fig. 3),
seemed to be one of the promising therapeutic modalities for the treat-
ment of eye diseases [98–100]. In 2006, an attempt was undertaken in
Skulachev's group to replace the ubiquinonemoiety inMitoQ by plasto-
quinone. As a result, a series of mitochondria-targeted antioxidants
named SkQ has been synthesized [79,101]. It was reported [102–104]
that the reactivity of the “tailless” plastoquinol analogs to the peroxyl
radicals was higher than that of natural ubiquinols. The technique
based on monitoring oxygen consumption was applied to study 12
alkyl- and methoxy-substituted p-hydroquinones (QH(2)) as a chain-
breaking antioxidant during the oxidation of styrene andmethyl linole-
ate (ML) in bulk as well as ML oxidation in micellar solution of sodium
dodecyl sulfate (SDS) at 37 °C. The antioxidant activities of QH(2) were
characterized by two parameters: the rate constant k(1) for reaction of
QH(2) with the peroxy radical LO(2)*:QH(2) + LO(2)*→ QH*+ LOOH
and the stoichiometric factor of inhibition, f, which shows howmany ki-
netic chains may be terminated by one molecule of QH(2) [103]. The
features of QH(2) as an antioxidant in aqueous environment are sug-
gested to associate with the reactivity of semiquinone (Q*(−)). Q*(−)
reacts readily with molecular oxygen with formation of superoxide
(O(2)*(−)); further reactions of O(2)*(−) result in fast depleting
QH(2) and chain propagation. The addition of SOD results in purging a
reaction mixture from O(2)*(−) and, as a corollary, in depressing
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oxidation models, QH(2) were found to be very reactive to LO(2)*
[103]. All the tested QH(2) displayed a pronounced antioxidant activity.
The oxidized formsof the same compounds did not inhibitML peroxida-
tion. The value of k(1) for SkQH(2) far exceeded k(1) forMitoQH(2). For
the biologically active geroprotectors SkQ1H(2), the k(1) value found to
be as high as 2.2 × 10(5) M(−) (1)s(−) (1), whereas for MitoQH(2),
it was 0.58 × 10(5) M(−) (1)s(−) (1). The kinetic behavior of
QH(2) suggested that SkQ1H(2) can rather easily diffuse through
lipid–water microheterogeneous systems [105].
Mitochondria-targeted cationic plastoquinone derivative SkQ1 (10-
(6′-plastoquinonyl) decyltriphenylphosphonium) has been investigat-
ed as a potential tool for treating a number of ROS-related ocular dis-
eases [106]. In OXYS rats suffering from a ROS-induced progeria, very
small amounts of SkQ1 (50 nmol/kg per day) added to food were
found to prevent development of age-induced cataract and retinopa-
thies of the eye, lipid peroxidation and protein carbonylation in skeletalFig. 4. Concept of targeting mitochondria with functional agents (1–9) that use a vehicle to demuscles, as well as a decrease in bone mineralization. Instillation of
drops of 250 nM SkQ1 reversed cataract and retinopathies in 3–12-
month-old (but not in 24-month-old) OXYS rats [106]. In ex vivo
studies of cultivated posterior retina sector, it was found that 20 nM
SkQ1 strongly decreased macrophagal transformation of the retinal
pigmented epithelial cells, an effect which might explain some of the
above SkQ1 activities. It is concluded that low concentrations of SkQ1
are promising in treating retinopathies, cataract, uveitis, glaucoma,
and some other ocular diseases [106].
The concentration and distribution of oxygen within the lens is of
considerable interest clinically. In age-related cataracts, cytosolic and
membrane components are subjected to free-radical induced oxidation
extensively. The identity of the oxidant(s) responsible has not been
established unequivocally. Because oxidative damage plays a key role
in cataract pathology, it has been suggested that possible hypoxic dam-
age would have to be carefully controlled in the lens. It is important to
note that about half of the lens is made up of differentiating ﬁbersliver an ROS scavenging payload into mitochondria (for details, see Section 7 in the text).
Fig. 4 (continued).
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Therefore themaintenance of healthymitochondria is critical to prevent
lens damage during hypoxia. Oxidized phospholipids play an important
role in execution of the mitochondrial stage of apoptosis and clearance
of apoptotic cells. During the lipid peroxidation (LPO) reaction, lipid hy-
droperoxides are formed as primary products. Several lines of evidence
suggest that lipid hydroperoxides can trigger cell death in many cell
types, which may be mediated by mitochondria dysfunction pathway.
With extended hyperoxic insult, the oxidants overwhelm the antioxi-
dant defense system and eventually cell death ensues [108]. ROS gener-
ation correlated inversely with mitochondrial membrane potential and
the amount of cardiolipin, factors likely to contribute to loss of cell via-
bility [108].
The critical role of mitochondria in programmed cell death leads to
the design of mitochondriotropic agents as a strategy in regulating
apoptosis. According to the new IVPmitochondrion concept, mitochon-
dria do not exist stably as distinct, individual, autonomous organelles[108–112]. Rather,mitochondria form a networkwithin cells; their con-
tinuous fusion and ﬁssion is a highly dynamic process, adapting to the
role the mitochondrion actually has in the cell. Increasing results con-
ﬁrm the role of mitochondrial ﬁssion and fragmentation in most forms
of apoptosis, even as a cause. This suggests that fragmented mitochon-
dria are in a “bad” condition, under oxidative stress. To overcome this
problem, we developed natural forms of mitochondria-targeted
antioxidants (Fig. 3 (1)), non-hydrolyzed carnosine associated with
the ophthalmic carrier typiﬁed for topical use (N-acetylcarnosine
lubricant eye drops) (major proposed administration way), ocular
injection (intra-vitreal, subconjunctival, parabulbar) or even oral
administration (synergistic administration with chaperones and
reduced glutathione synthesis booster) [109–112].
The effect of carnosine on self-organization of mitochondrial assem-
blies was studied in rat liver homogenate of quiescent and excited
animals. It was shown in separate electron microscopy experiments
with serial slices that under our conditions of preparation of
homogenate, blocks of native mitochondrial–reticular network in
the cell, assemblies of mitochondria, are kept. Carnosine was shown
to prevent dissociation of assemblies during storage. Its effect is maxi-
mal for more dissociated assemblies from excited animals with de-
creased ability for self-organization. Prevention of disassembly of
organelles by carnosine can serve as one of the mechanisms of
carnosine-induced diminishing of muscle fatigue under prolonged
work [113]. L-Carnosine prevented both 12-O-tetradecanoylphorbol-
13-acetate (TPA)- andH2O2-inducedDNA fragmentation, the loss ofmi-
tochondrial membrane potentials and blocked the release of cyto-
chrome c into cytosol. Subsequently, the cleavages of poly (ADP-
ribose) polymerase were signiﬁcantly reduced in L-carnosine-treated
cells. However, western blotting analysis revealed that p53 protein
level did not change for 12 h after TPA- and H2O2-treatment.
Therefore, these results suggested that L-carnosine, an antioxidant,
protected both H2O2- and TPA-induced apoptosis throughmitochondri-
al pathways [114]. Carnosine addition to mitochondria or its accumula-
tion in mitochondria under hypoxia is associated with activation of
alpha-ketoglutarate oxidation and its formation through transamina-
tion [115].
Recently, phospholipid peroxidation products gained a reputation
as key regulatory molecules and participants in oxidative signaling
pathways. Oxidation of two anionic phospholipids – cardiolipin (CL)
in mitochondria and phosphatidylserine (PS) in extramitochondrial
compartments – is important signaling event, particularly during the
execution of programmed cell death and clearance of apoptotic cells.
Quantitative analysis of CL and PS oxidation products is central to un-
derstanding their molecular mechanisms of action [116,117]. Further-
more, speciﬁc characteristics of CL in mitochondria – its asymmetric
transmembrane distribution and mechanisms of collapse, the regula-
tion of its synthesis, remodeling, and fatty acid composition – are
given signiﬁcant consideration [117,118]. Cytochrome c (cyt c) acts as
a CL-speciﬁc peroxidase very early in apoptosis. At this stage, the hostile
events are still secluded within the mitochondria and do not reach the
cytosolic targets. CL oxidation process is required for the release of
pro-apoptotic factors into the cytosol. Manipulation of cyt c interactions
with CL, inhibition of peroxidase activity, and prevention of CL peroxi-
dation are prime targets for the discovery of anti-apoptotic drugs acting
before the “point-of-no-return” in the fulﬁllment of the cell death
program. During apoptosis, a mitochondria-speciﬁc phospholipid,
cardiolipin (CL), interacts with cytochrome c (cyt c) to form a peroxi-
dase complex that catalyzes CL oxidation; this process plays a pivotal
role in the mitochondrial stage of the execution of the cell death pro-
gram. Several works were focused on redox mechanisms and essential
structural features of cyt c's conversion into a CL-speciﬁc peroxidase
that represent an interesting andmay be still unique example of a func-
tionally signiﬁcant ligand change in hemoproteins [116,117].
Recently, it was demonstrated that peroxidase cyt c/CL complexes
can utilize free fatty acid hydroperoxides (FFA-OOH) at exceptionally
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H2O2 [116].
Accordingly, the new concepts in drug discovery based on the design
of mitochondria-targeted inhibitors of cyt c/CL peroxidase and CL
peroxidation with antiapoptotic effects have appeared. Therefore,
mitochondria-targeted disruptors and inhibitors of cyt c/CL peroxidase
complexes and suppression of CL peroxidation represent new strategies
in anti-apoptotic drug discovery [119]. We have originally discovered
that both carnosine and carcinine (10–25mM) are capable of inhibiting
the catalysis of linoleic acid and phosphatidylcholine liposomal peroxi-
dation (LPO) by the O2−•-dependent iron-ascorbate and lipid-peroxyl-
radical-generating linoleic acid 13-monohydroperoxide (LOOH)-acti-
vated hemoglobin systems, asmeasured by thiobarbituric-acid-reactive
substance. Carcinine and carnosine are good scavengers of OH• radicals,
as detected by iron-dependent radical damage to the sugar deoxyribose.
This suggests that carnosine and carcinine are able to scavenge free rad-
icals or donate hydrogen ions. The iodometric, conjugated diene and
t.l.c. assessments of lipid hydroperoxides (13-monohydroperoxide
linoleic acid and phosphatidylcholine hydroperoxide) showed their ef-
ﬁcient reduction and deactivation by carnosine and carcinine (10–
25 mM) in the liberated and bound-to-artiﬁcial-bilayer states. This
suggests that the peroxidase activity exceeded that susceptible to direct
reduction with glutathione peroxidase. Imidazole, solutions of beta-
alanine, or their mixtures with peptide moieties did not show antioxi-
dant potential [120]. Due to the combination of weak metal chelating
(abolished by EDTA), OH• and lipid peroxyl radicals scavenging, reduc-
ing activities to liberated fatty acid and phospholipid hydroperoxides,
carnosine and carcinine appear to be physiological antioxidants able
to efﬁciently protect the lipid phase of biological membranes and aque-
ous environments and act as the anti-apoptotic natural drug com-
pounds. Removal of excessive mitochondrial reactive oxygen species
by electron scavengers and antioxidants is a promising therapeutic
strategy to reduce the detrimental effects of UV radiation and other
cataractogenic factors exposure. Local mitochondrial interaction is me-
diated by superoxide (O2−•) diffusion and the O2−•-dependent activation
of an inner membrane anion channel (IMAC). In contrast to other
mitochondria-targeted antioxidants studied byMitchel and Skulachev's
groups, it is important that L-carnosine can scavenge superoxide anion
radical released from mitochondria in the outside compartments of
the cells. Even at low concentrations, dipeptide carnosine forms a
charge-transfer complex (Car … O2−•, lambda max = 265 nm) with
the superoxide radical which changes the reactivity of O2−•. The absor-
bance band of the complex was shifted towards lower energy as com-
pared to superoxide radical lambda max = 255 nm). The interaction
of carnosinewithOH-radicals proceeding at very high rate and resulting
in the formation of a stable product suggested another type of dipeptide
activity [121].
The IVP patented concept includes the integrated lens and ocular
tissues mitochondrial targeting with triphenyl-phosphonium (TPP)-
conjugated hydrophobic compounds combined with L-carnosine oph-
thalmic prodrug N-acetylcarnosine (Fig. 4), represents a promising ap-
proach for the development of novel eye and speciﬁcally, cataract
universal antioxidant protectors [109,110].8. Conclusion
In addition to the well-established role of the mitochondria in ener-
gy metabolism, regulation of cell death has recently emerged as a sec-
ond major function of these organelles. This, in turn, seems to be
intimately linked to their role as the major intracellular source of reac-
tive oxygen species (ROS) which are mainly, generated at complex I
and III of the respiratory chain. Excessive ROS production can lead to ox-
idation of macromolecules and has been implicated in mtDNA muta-
tions, aging, and cell death. Although mitochondrial dysfunction can
cause ATP depletion and necrosis, these organelles are also involved inthe regulation of apoptotic cell death by mechanisms, which have
been conserved through evolution [122].
A great deal of research indicates that dysfunctional mitochondria
are the primary site of ROS [122–124]. More than 95% of O2−• produced
during normal metabolism is generated by the electron transport chain
in the inner mitochondrial membrane. Ironically, mitochondria are also
themajor target of ROS [122]. Mitochondrial DNAmay bemore suscep-
tible to oxidative damage than to nuclear DNA [125] because of its prox-
imity to electron transport chains, lack of protective histones, and
insufﬁcient repair mechanisms [126]. Such damage to themitochondri-
al DNA may contribute to the age-associated decline in mitochondrial
function. Furthermore, mitochondrial DNA encodes several subunits of
different respiratory complexes [127]. The essential role of mitochon-
drial oxidative phosphorylation in cellular energy production, the gen-
eration of reactive oxygen species, and the initiation of apoptosis has
suggested a number of novel mechanisms for mitochondrial pathology
in sight-threatening eye diseases, including age-related cataract forma-
tion. ROS-induced DNA damage may lead to the production of more
ROS, thus perpetuating a vicious cycle. Following publication of these
data, it was suggested that penetrating cations can be used as “molecu-
lar electric locomotives” to target uncharged substances attached to
these cations speciﬁcally to mitochondria [97,128].
As reported in the preceding studies (reviewed in Refs. [106,129]),
very small amounts of mitochondria-targeted plastoquinone deriva-
tives (SkQs) show pronounced antioxidant effects on model mem-
branes, isolated mitochondria, and cell cultures. In the latter case,
strong antiapoptotic and antinecrotic effects were observed in situa-
tions when cell death was induced or mediated by reactive oxygen spe-
cies (ROS) (reviewed in Refs. [106,129]). N-acetylcarnosine eye-drops
have been shown to havemeasurable affects to prevent and partially re-
verse cataracts within only 3–6-month of topical ocular use [112,124].
However, it is recommended that for maximum efﬁcacy, that adminis-
tration be continued for a period not less than 3–5 months. In addition,
the drops' effectiveness is increased the sooner they are used after a cat-
aract is detected.
Also, considering that senile cataracts are an on-going aging
disorder, N-acetylcarnosine may be required on a regular basis to
help maintain the eye's natural anti-oxidant defenses. Other than
senile cataract, N-acetylcarnosine may have other beneﬁts. The unique
N-acetylcarnosine formula with its added and synergistic lubricants,
could also provide beneﬁcial results with the following eye-disorders
[112,124]:
• Presbyopia
• Open-angle primary glaucoma (in combination with beta-blockers)
• Corneal disorders
• Computer vision syndrome
• Eye strain
• Ocular inﬂammation
• Blurred vision
• Dry eye syndrome
• Retinal diseases
• Vitreous opacities and lesions
• Complications of diabetes mellitus and other systemic diseases
• Contact lens difﬁculties, particularly with soft contact lenses.
(Not only do the lubricants in the Can-C N-acetylcarnosine eye-drop
help to make wearing contact lenses more comfortable, but n-
acetylcarnosine is also believed to reduce the buildup of lactic acid
in the eye, thus enabling the lens to be left safely in the eye for longer).
There are numerous indications of a crucial role of ROS in the main
age-related ocular pathologies, i.e. retinopathies (age-related macular
degeneration [130,131], retinitis pigmentosa [132,133], hereditary
optic neuropathy [134]), as well as glaucoma [135–137], cataract [112,
138,139], and autoimmune uveitis [140,141]. Polyunsaturated fatty
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dria produced ROS that are quenched by the considered natural
and synthetic mitochondria-targeted antioxidants (Fig. 4) [112,142].
Mitochondria-targeted antioxidants might be used to effectively pre-
vent ROS-induced oxidation of lipids and proteins in the inner mito-
chondrial membrane in vivo [142].
This review article demonstrates that mitochondria are an im-
portant source of toxic oxygen radicals in the onset of age-related cata-
racts and conﬁrms new approaches for treating cataracts using
mitochondria-targeted antioxidants (Fig. 5).
Mitochondria are usually either the primary source of ROS [143] or
mediators of burst of ROS formation in other cellular compartments
(“ROS-induced ROS release” [142,144]). This is why it is reasonable to
combine the N-acetylcarnosine lubricant eye drops acting as the oph-
thalmic prodrug of naturally targeted to mitochondria L-carnosine
endowed with pluripotent types of antioxidant activities with
mitochondria-targeted rechargeable antioxidant (see a number of
compounds presented in Fig. 3) as a medicine to treat ocular diseases
[109–112,120,124].
We conclude that mitochondrial targeting of compounds with uni-
versal of antioxidant activities represents a promising approach for theFig. 5. Human cataract reversal within 5 months of treatment with 1% N-acetylcarnosine
lubricant eye drops (carrier ophthalmic system equipped with corneal absorption
promoter for natural mitochondria-targeted antioxidant L-carnosine). Upper image:
The lens before treatment; lower image: after 5 months of daily treatment with 1% N-
acetylcarnosine lubricant eye drops (for details, see Ref. [124]).development of novel therapeutic protectors of the aging eye and can
be implicated in the management of cataracts.
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